Lupin Ltd share price ticked higher by 0.77% to Rs 2012.0. The Company's net profit contracted by 18.47% to Rs 1155.3 crore, while revenue from operations softened by 5.25% to Rs 7785.52 crore in Q3FY26 over Q2FY26.

The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.73 lakh crore, rising 4.36%. It has improved by 1.84% over last one week and moved up slightly by 1.37% in last one month while the market capitalization of Lupin Ltd has marginally improved by 2.08% and 15.86% in the same period respectively.

Profit before tax (PBT) of Lupin Ltd stood at Rs 1579.6 crore in Q3 FY26, plunging by 21.29% year-on-year, and tumbling by 21.70% quarter-on-quarter. EBITDA came in at Rs 1918 crore, dropping 14.82% YoY and nosediving by 17.32% sequentially.

Total expenses marginally dropped 0.18% to Rs 6268.75 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1310.74 crore, slightly declining by 0.07% YoY, while employee benefits expense was at Rs 1423.58 crore, ticking higher by 2.93% YoY.

For the TTM ended FY26, revenue from operations witnessed a strong growth of 23.86% to Rs 27487.54 crore, while net profit jumped 61.98% to Rs 5355.47 crore, compared to previous TTM. EBITDA jumped by 529273% to Rs 8391.55 crore, and PBT soared 71.17% to Rs 6872.55 crore compared to previous TTM.

The company's consolidated net cash flow from operating activities stood at Rs 7334.5 crore in FY26, as against Rs 2999.94 crore in FY25.

Lupin Ltd inched up 1.32% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 8.41% during the same period.